ECR 2010: New Data on CMC-001

Posted February 18, 2010 by Cmc cmc

At the coming European Congress of Radiology in Vienna from March 4 to 8, 2010, new data on the novel non-gadolinium based oral contrast agent for liver MRI will be presented. On March 8 at 2 o’clock in the afternoon data from a clinical phase II study with CMC-001 will be presented by Dr. Matthias Reif, Institut Fûr Radiologie, Charité – Universitetätsmedicin, Berlin, Germany. His presentation will be given in the scientific session “Liver MR: High field and contrast media advantages” and is entitled; “Diagnostic time window for liver MRI after administration of an oral manganese-based contrast agent (CMC-001)”.

For further information on CMC-001 please contact:
Director of Business Development Thomas Grönberg - E-mail:
or
Director of Medical Affairs Jan Trøst Jørgensen – E-mail: